Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 586

1.

Study protocol: Worldwide comparison of vitamin D status of immigrants from different ethnic origins and native-born populations-a systematic review and meta-analysis.

Yousef S, Elliott J, Manuel D, Colman I, Papadimitropoulos M, Hossain A, Leclair N, Wells GA.

Syst Rev. 2019 Aug 22;8(1):211. doi: 10.1186/s13643-019-1123-4.

PMID:
31439035
2.

Nordic walking and standard exercise therapy in patients with chronic heart failure: A randomised controlled trial comparison.

Prince SA, Wooding E, Mielniczuk L, Pipe AL, Chan KL, Keast ML, Harris J, Tulloch HE, Mark AE, Cotie LM, Wells GA, Reid RD.

Eur J Prev Cardiol. 2019 Aug 19:2047487319871215. doi: 10.1177/2047487319871215. [Epub ahead of print] No abstract available.

PMID:
31426669
3.

Viral composition and context in metagenomes from biofilm and suspended growth municipal wastewater treatment plants.

Petrovich ML, Ben Maamar S, Hartmann EM, Murphy BT, Poretsky RS, Wells GF.

Microb Biotechnol. 2019 Aug 14. doi: 10.1111/1751-7915.13464. [Epub ahead of print]

4.

Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review.

Elliott J, Kelly SE, Bai Z, Liu W, Skidmore B, Boucher M, So DYF, Wells GA.

Can J Cardiol. 2019 Aug;35(8):1039-1046. doi: 10.1016/j.cjca.2019.01.021. Epub 2019 Feb 6. Review.

PMID:
31376905
5.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, Büller HR, Rodger MA; MARVELOUS Collaborators.

BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.

6.

Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta-analysis.

Johnston A, Smith C, Zheng C, Aaron SD, Kelly SE, Skidmore B, Wells GA.

Clin Exp Allergy. 2019 Jul 11. doi: 10.1111/cea.13457. [Epub ahead of print] Review.

PMID:
31295369
7.

Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure.

Manlucu J, Sharma V, Koehler J, Warman EN, Wells GA, Gula LJ, Yee R, Tang AS.

J Am Heart Assoc. 2019 Jul 16;8(14):e010998. doi: 10.1161/JAHA.118.010998. Epub 2019 Jul 11.

8.

Towards mechanical characterization of granular biofilms by optical coherence elastography measurements of circumferential elastic waves.

Liou HC, Sabba F, Packman AI, Rosenthal A, Wells G, Balogun O.

Soft Matter. 2019 Jul 17;15(28):5562-5573. doi: 10.1039/c9sm00739c.

PMID:
31282532
9.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].

Wells GA, Elliott J, Kelly S, Bai Z, Boucher M, Skidmore B, So D, Laplante S, Lee K.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.

10.

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review.

Elliott J, Kelly SE, Bai Z, Skidmore B, Boucher M, So DYF, Wells GA.

BMJ Open. 2019 Jun 16;9(6):e022271. doi: 10.1136/bmjopen-2018-022271.

11.

Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.

Elliott J, van Katwyk S, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D.

Pharmacoeconomics. 2019 Jun 14. doi: 10.1007/s40273-019-00816-2. [Epub ahead of print] Review.

PMID:
31201643
12.

Tramadol for osteoarthritis.

Toupin April K, Bisaillon J, Welch V, Maxwell LJ, Jüni P, Rutjes AW, Husni ME, Vincent J, El Hindi T, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2019 May 27;5:CD005522. doi: 10.1002/14651858.CD005522.pub3.

PMID:
31132298
13.

Development of a clinical decision support tool for diagnostic imaging use in patients with low back pain: a study protocol.

Hayden JA, Ogilvie R, Stewart SA, French S, Campbell S, Magee K, Slipp P, Wells G, Stiell I.

Diagn Progn Res. 2019 Jan 14;3:1. doi: 10.1186/s41512-019-0047-8. eCollection 2019.

14.

Global diversity and biogeography of bacterial communities in wastewater treatment plants.

Wu L, Ning D, Zhang B, Li Y, Zhang P, Shan X, Zhang Q, Brown M, Li Z, Van Nostrand JD, Ling F, Xiao N, Zhang Y, Vierheilig J, Wells GF, Yang Y, Deng Y, Tu Q, Wang A; Global Water Microbiome Consortium, Zhang T, He Z, Keller J, Nielsen PH, Alvarez PJJ, Criddle CS, Wagner M, Tiedje JM, He Q, Curtis TP, Stahl DA, Alvarez-Cohen L, Rittmann BE, Wen X, Zhou J.

Nat Microbiol. 2019 Jul;4(7):1183-1195. doi: 10.1038/s41564-019-0426-5. Epub 2019 May 13.

PMID:
31086312
15.

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.

Essebag V, AlTurki A, Proietti R, Healey JS, Wells GA, Verma A, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leather R, Ahmad K, Toal S, Sapp J, Sturmer M, Kavanagh K, Crystal E, Leiria TLL, Seifer C, Rinne C, Birnie D; BRUISE CONTROL Investigators.

Int J Cardiol. 2019 Aug 1;288:87-93. doi: 10.1016/j.ijcard.2019.04.066. Epub 2019 Apr 26.

PMID:
31056413
16.

Microbial immigration in wastewater treatment systems: analytical considerations and process implications.

Frigon D, Wells G.

Curr Opin Biotechnol. 2019 Jun;57:151-159. doi: 10.1016/j.copbio.2019.02.021. Epub 2019 Apr 28. Review.

PMID:
31030172
17.

Comammox Nitrospira are the dominant ammonia oxidizers in a mainstream low dissolved oxygen nitrification reactor.

Roots P, Wang Y, Rosenthal AF, Griffin JS, Sabba F, Petrovich M, Yang F, Kozak JA, Zhang H, Wells GF.

Water Res. 2019 Jun 15;157:396-405. doi: 10.1016/j.watres.2019.03.060. Epub 2019 Mar 28.

PMID:
30974288
18.

Exploring co-occurrence patterns between organic micropollutants and bacterial community structure in a mixed-use watershed.

Gao H, LaVergne JM, Carpenter CMG, Desai R, Zhang X, Gray K, Helbling DE, Wells GF.

Environ Sci Process Impacts. 2019 May 22;21(5):867-880. doi: 10.1039/c8em00588e.

PMID:
30957808
19.

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.

Elliott J, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D.

Syst Rev. 2019 Mar 27;8(1):75. doi: 10.1186/s13643-019-0990-z.

20.

Genome-centric metagenomics resolves microbial diversity and prevalent truncated denitrification pathways in a denitrifying PAO-enriched bioprocess.

Gao H, Mao Y, Zhao X, Liu WT, Zhang T, Wells G.

Water Res. 2019 May 15;155:275-287. doi: 10.1016/j.watres.2019.02.020. Epub 2019 Feb 20.

PMID:
30852315
21.

Spatial Abilities Training in Anatomy Education: A Systematic Review.

Langlois J, Bellemare C, Toulouse J, Wells GA.

Anat Sci Educ. 2019 Mar 6. doi: 10.1002/ase.1873. [Epub ahead of print]

PMID:
30839169
22.

Granular activated carbon supplementation alters the metabolic flux of Clostridium butyricum for enhanced biohydrogen production.

Park JH, Kim DH, Kim HS, Wells GF, Park HD.

Bioresour Technol. 2019 Jun;281:318-325. doi: 10.1016/j.biortech.2019.02.090. Epub 2019 Feb 25.

PMID:
30826518
23.

Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.

Yadav K, Suh KN, Eagles D, Thiruganasambandamoorthy V, Wells GA, Stiell IG.

Am J Emerg Med. 2019 Feb 21. pii: S0735-6757(19)30107-X. doi: 10.1016/j.ajem.2019.02.023. [Epub ahead of print]

PMID:
30824277
24.

Biomass segregation between biofilm and flocs improves the control of nitrite-oxidizing bacteria in mainstream partial nitritation and anammox processes.

Laureni M, Weissbrodt DG, Villez K, Robin O, de Jonge N, Rosenthal A, Wells G, Nielsen JL, Morgenroth E, Joss A.

Water Res. 2019 May 1;154:104-116. doi: 10.1016/j.watres.2018.12.051. Epub 2019 Jan 7.

25.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
26.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
27.

Prolonged versus brief balloon inflation during arterial angioplasty for de novo atherosclerotic disease: protocol for a systematic review.

Rockley M, Jetty P, Wells G, Rockley K, Fergusson D.

Syst Rev. 2019 Feb 5;8(1):45. doi: 10.1186/s13643-019-0955-2.

28.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
29.

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.

Milman N, McConville E, Robson JC, Boonen A, Tugwell P, Wells GA, Chaudhuri D, Dawson J, Tomasson G, Ashdown S, Gebhart D, Lanier G, Peck J, McAlear CA, Kellom KS, Cronholm PF, Merkel PA.

J Rheumatol. 2019 Feb 1. pii: jrheum.181073. doi: 10.3899/jrheum.181073. [Epub ahead of print]

PMID:
30709951
30.

Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope.

Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, McRae AD, Arcot K, Nemnom MJ, Huang L, Mukarram M, Krahn AD, Wells GA, Taljaard M.

Circulation. 2019 Mar 12;139(11):1396-1406. doi: 10.1161/CIRCULATIONAHA.118.036088.

PMID:
30661373
31.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.

PMID:
30647191
32.

The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study.

Sloan VS, Grosskleg S, Wells G, Singh JA.

J Rheumatol. 2019 Aug;46(8):1036-1040. doi: 10.3899/jrheum.181196. Epub 2019 Jan 15.

PMID:
30647187
33.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Jan 15. pii: jrheum.181081. doi: 10.3899/jrheum.181081. [Epub ahead of print]

PMID:
30647174
34.

Minimally Invasive coronary surgery compared to STernotomy coronary artery bypass grafting: The MIST trial.

Guo MH, Wells GA, Glineur D, Fortier J, Davierwala PM, Kikuchi K, Lemma MG, Mishra YK, McGinn J, Ramchandani M, Rabindra P, Nambala S, Chiu KM, Kiaii B, Gibson S, Ruel M.

Contemp Clin Trials. 2019 Mar;78:140-145. doi: 10.1016/j.cct.2019.01.006. Epub 2019 Jan 8.

PMID:
30634037
35.

Nondestructive characterization of soft materials and biofilms by measurement of guided elastic wave propagation using optical coherence elastography.

Liou HC, Sabba F, Packman AI, Wells G, Balogun O.

Soft Matter. 2019 Jan 28;15(4):575-586. doi: 10.1039/c8sm01902a. Epub 2019 Jan 2.

PMID:
30601536
36.

The use of information and communication technologies by arthritis health professionals to disseminate a self-management program to patients: a pilot randomized controlled trial protocol.

De Angelis G, Brosseau L, Davies B, King J, Wells GA.

Digit Health. 2018 Dec 17;4:2055207618819571. doi: 10.1177/2055207618819571. eCollection 2018 Jan-Dec.

37.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH.

Europace. 2018 Dec 7. doi: 10.1093/europace/euy285. [Epub ahead of print]

PMID:
30535367
38.

Systematic reviews of clinical practice guidelines: a methodological guide.

Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA.

J Clin Epidemiol. 2019 Apr;108:64-76. doi: 10.1016/j.jclinepi.2018.11.030. Epub 2018 Dec 5.

PMID:
30529647
39.

Cannabis-based products for pediatric epilepsy: A systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA.

Epilepsia. 2019 Jan;60(1):6-19. doi: 10.1111/epi.14608. Epub 2018 Dec 4.

PMID:
30515765
40.

Spatially resolved abundances of antibiotic resistance genes and intI1 in wastewater treatment biofilms.

Petrovich ML, Rosenthal AF, Griffin JS, Wells GF.

Biotechnol Bioeng. 2019 Mar;116(3):543-554. doi: 10.1002/bit.26887. Epub 2019 Jan 4.

PMID:
30512194
41.

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Brinkhurst J, Wells GA.

CMAJ. 2018 Dec 3;190(48):E1406-E1413. doi: 10.1503/cmaj.180232.

42.

Postablation Atrial Fibrillation Burden and Patient Activity Level: Insights From the DISCERN AF Study.

Proietti R, Birnie D, Ziegler PD, Wells GA, Verma A.

J Am Heart Assoc. 2018 Dec 4;7(23):e010256. doi: 10.1161/JAHA.118.010256.

43.

Diagnosing hypertension in Indigenous Canadians (DREAM-GLOBAL): A randomized controlled trial to compare the effectiveness of short message service messaging for management of hypertension: Main results.

Tobe SW, Yeates K, Campbell NRC, Maar MA, Perkins N, Liu PP, Sleeth J, McAllister C, Hua-Stewart D, Wells G, Bernick J.

J Clin Hypertens (Greenwich). 2019 Jan;21(1):29-36. doi: 10.1111/jch.13434. Epub 2018 Nov 26.

44.
45.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
46.

From Good to Great: The Role of Performance Coaching in Enhancing Tobacco-Dependence Treatment Rates.

Papadakis S, Cole AG, Reid RD, Assi R, Gharib M, Tulloch HE, Mullen KA, Wells G, Pipe AL.

Ann Fam Med. 2018 Nov;16(6):498-506. doi: 10.1370/afm.2312.

47.

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making.

Johnston A, Hsieh SC, Carrier M, Kelly SE, Bai Z, Skidmore B, Wells GA.

PLoS One. 2018 Nov 9;13(11):e0207410. doi: 10.1371/journal.pone.0207410. eCollection 2018.

48.

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.

Andrade JG, Champagne J, Deyell MW, Essebag V, Lauck S, Morillo C, Sapp J, Skanes A, Theoret-Patrick P, Wells GA, Verma A; EARLY-AF Study Investigators.

Am Heart J. 2018 Dec;206:94-104. doi: 10.1016/j.ahj.2018.05.020. Epub 2018 Oct 18.

PMID:
30342299
49.

Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation [Internet].

Wells GA, Smith C, Hossain A, Karsh J, Singh J, Hazlewood G, Tugwell P.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar.

50.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Review of the Clinical Impact of Treatment Duration [Internet].

Wells GA, Elliott J, Kelly S, So D, Boucher M, Bai Z, Liu W, Skidmore B.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug.

Supplemental Content

Loading ...
Support Center